Educational Background

B.S. in Medicine, Ulsan University, Ulsan, Republic of Korea

M.D. in Medicine, Ulsan University, Ulsan, Republic of Korea

Ph,D in Medicine, Ulsan University, Ulsan, Republic of Korea

Professional Career

Internship, Asan Medical Center

Residency, Department of Internal Medicine, Asan Medical Center

Clinical fellowship, Department of Pulmonology and Critical Care Medicine, Asan Medical Center

Assistant Professor, Department of Pulmonology and Critical Care Medicine, Asan Medical Center

Research Field

Pulmonary hypertension

Venous thromboembolism

Airway disease

Educational Background

1993년 3월 ~ 1999년 2월 고려대학교 의과대학 의학사

2002년 3월 ~ 2004년 2월 고려대학교 의과대학 대학원 의학 석사 (내과학)

2004년 3월 ~ 2007년 2월 고려대학교 의과대학 대학원 의학 박사 (순환기내과)

Professional Career

1999년 3월 ~ 2000년 2월 고려대학교 병원 수련의

2000년 3월 ~ 2004년 2월 고려대학교 병원 내과 전공의

2004년 3월 ~ 2007년 2월 고려대학교 병원 순환기 내과 전임의/임상강사

2007년 5월 ~ 2009년 4월 Brigham and Women’s Hospital Research Fellow

2009년 5월 ~ 2010년 2월 인하대학교 병원 심장내과 임상강사

2010년 3월 ~ 2014년 2월 인하대학교 병원 심장내과 조교수

2014년 3월 ~ 2019년 2월 인하대학교 병원 심장내과 부교수

2018년 ~ 2019년 Brigham and Women’s Hospital Visiting Associate Professor

2019년 3월 ~ 현재 인하대학교 병원 심장내과 교수

학회

대한내과학회 현) 윤리위원

대한심장학회 현) 편집위원, 정책위원

한국심초음파학회 현) 홍보이사

대한심부전학회 현) 국제교류이사

대한고혈압학회 현) 홍보위원

Educational Background

Professor Aldalaan earned his medical degree from King Saud University. He completed residencies in internal medicine at King Faisal Specialist Hospital & Research Centre and Duke University Medical Center. He then completed a pulmonary and critical care fellowship at the University of Virginia.

Professional Career

Abdullah Moshin Aldalaan, MBBS, is Director of the Pulmonary Hypertension Program of Excellence and a Consultant Pulmonologist at the King Faisal Specialist Hospital & Research Centre in Riyadh, Saudi Arabia. He also serves as a Professor in the College of Medicine at Alfaisal University, also located in Riyadh. In addition to his current role as President of the Saudi Association for Pulmonary Hypertension, Dr. Aldalaan has held leadership positions in numerous professional societies focused on respiratory disease and has lectured nationally and internationally.

Research Field

Dr. Aldalaan established the lung transplant program at King Faisal Specialist Hospital & Research Centre in 2003. He also established the institution’s pulmonary hypertension (PH) treatment program, which is the only program in the area providing comprehensive diagnostic and therapeutic protocols for patients with PH. The program offers all available internationally recognized medical interventions for PH and has become a region-wide reference center for pulmonary hypertension education and treatment.

Papers, Books, etc. presented or published by your name

Dr. Aldalaan also is an active clinical trialist and has published more than 50 papers in peer-reviewed journals.

Recent publication of note:
Aldalaan A, Saleemi SA, Weheba I, et al. Prospective clinical assessment of patients with pulmonary arterial hypertension switched from bosentan to macitentan (POTENT). Pulm Circ. 2022;12:e12083, doi: 10.1002/pul2.12083.

Educational Background

Apr 1982- Mar 1988 MD; Okayama University Medical School

May 1988- Apr 1990 National Okayama Hospital, Department of Internal Medicine, Residency

May 1990- Apr 1993 National Cardiovascular Center, Department of Cardiology, Residency

Sep 2000 PhD; Okayama University Graduate School of Medicine and Dentistry

Professional Career

Okayama University Graduate School of Medicine and Dentistry, Department of Cardiology; Associate Professor (May 2000- Apr 2003)

National Hospital Organization, Okayama Medical Center, Department of Cardiology; Director (May 2003- Mar 2020, Department of Clinical Science; Director (May 2010- Mar 2019), Entire Medical Departments; Director (Apr 2019 - Mar 2021), Vice President (Apr 2021 – active)

Research Field

clinical and physiological aspects of pulmonary hypertension

diagnosis and treatment of Group I PH

Interventional treatment of Group IV PH

Papers, Books, etc. presented or published by your name

JACC Cardiovasc Interv. 2024;17:707-708. doi: 10.1016/j.jcin.2023.11.022

Eur Respir J. 2024. doi: 10.1183/13993003.01294-2024

Can J Cardiol. 2024. doi: 10.1016/j.cjca.2024.05.003

J Heart Lung Transplant. 2024. doi: 10.1016/j.healun.2024.05.007

Circulation. 2024. doi: 10.1161/CIRCULATIONAHA.124.068610

Educational Background

2004-2006 Postdoctoral Fellow, ANTOINE BECLERE Hospital, Université Paris-Sud (Paris XI, South Paris University), France

1994-1998 Doctor of Medicine (M.D.) in Internal Medicine (Cardiovascular Diseases), Peking Union Medical College (PUMC), China

1989-1994 Bachelor of Medicine (M.B.) in Clinical Medicine, Weifang Medical University, China

Professional Career

Zhi-Cheng Jing is Full Professor of Medicine, the Director of Cardiology Department in Guangdong Provincial People’s Hospital and the Vice-president of Guangdong Cardiovascular Institute. He is the Associate Editor of Journal of Thrombosis and Haemostasis, the Associate Editor of Heart, the Asia-Pacific Regional Editor of JACC, the deputy editor in chief of Chinese Journal of Cardiology, and the Section Editor of JACC Asia.

Research Field

Pulmonary Hypertension (PH)

Pulmonary Hypertensive Crisis

Pulmonary Embolism (PE)

Right Heart Circulation

Congenital Heart Disease (CHD)

Papers, Books, etc. presented or published by your name

1. Zhou YP, Wei YP, Yang YJ, et al. Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension. J Am Coll Cardiol. 2022;79(15):1477-1488.

2. Zhang ZJ, Liu C, Ma JL, et al. Prognostic Value of Plasma Immunoglobulin G N-Glycome Traits in Pulmonary Arterial Hypertension. J Am Coll Cardiol. 2024;84(12):1092-1103.

3. Wu XH, He YY, Chen ZR, et al. Single-cell analysis of peripheral blood from high-altitude pulmonary hypertension patients identifies a distinct monocyte phenotype. Nat Commun. 2023;14(1):1820. Published 2023 Mar 31.

4. Yan Y, He YY, Jiang X, et al. DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension. Sci Adv. 2020;6(50):eaba2470. Published 2020 Dec 9.

Educational Background

Visiting Scholar , University of Chicago Medical Center

PhD, Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan

Master Degree, Pulmonary Vascular Disease, University of Bologna, Bologna, Italy

MD, China Medical College, Taichung, Taiwan

Professional Career

2022- Clinical Professor, National Cheng Kung University

2023-, Deputy Superintendent, National Cheng Kung University Hospital

2020-2023 Medical Secretory, National Cheng Kung University Hospital

2019-2020 Deputy Superintendent, National Cheng Kung University Hospital Dou-Liou Branch

2004 Clinical Fellow, Cardiac Transplant Program, Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center

Research Field

Pulmonary Hypertension

Heart Failure

Heart Transplant Care

Critical Care

Post Resuscitation Care

Educational Background

1998-2004 Pusan National University, College of Medicine, Medicine, Bachelor

2005~2007 Pusan National University, College of Medicine, Internal medicine, MMed

2012~2013 Pusan National University, College of Medicine, Internal medicine, Ph.D.

Professional Career

Feb 2004 Korean Medical License (No. 82164)

Mar 2009 Korean Board of Internal Medicine (No. 11607)

Oct 2015 Korean Subspecialty Board of Cardiology (No. 2-15-1019)

Mar 2021~ present: Assistant Professor, Internal Medicine (Division of Cardiology), Pusan National University Yangsan Hospital, Yangsan, Korea

Research Field

Echocardiography,

Pulmonary Hypertension,

Hypertension / Dyslipidemia,

Cardiac amyloidosis / Cardiac Sarcoidosis

Papers, Books, etc. presented or published by your name

1. Value of Coronary Angiography in the Cardiac Myxoma. Clin Anat. 2019 Nov 21. doi: 10.1002/ca.23527

2. Mitral Loop Cerclage Annuloplasty for Secondary Mitral Regurgitation: First Human Results. JACC Cardiovasc Interv. 2017 Mar 27;10(6):597-610

3. Prognostic Significance of Presenting Blood Pressure in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Am J Hypertens. 2015 Jun;28(6):797-805.

4. Right Cardiac Catheterization Using the Antecubital Fossa Vein in Korean Patients. Korean Circ J. 2016 Mar;46(2):207-12.

Educational Background

Undergraduate/college: Davidson College, 2007-2011 – Bachelor of Science (BS)

Medical school: Jefferson Medical College at Thomas Jefferson University, 2011-2015 – Medical Degree (MD)

Internship/Residency: University of California San Diego, 2015-2018 – Internal Medicine

Fellowship: University of California San Diego, 2018-2021 – Pulmonary and Critical Care Medicine

Professional Career

Assistant Clinical Professor of Medicine, Pulmonary and Critical Care Medicine: University of California San Diego, 2021-2025

Staff Physician, Pulmonary and Critical Care Medicine: Veterans Affairs San Diego Medical Center, 2021-2023

Associate Clinical Professor of Medicine, Pulmonary and Critical Care Medicine: University of California San Diego, 2025-present

Research Field

Chronic thromboembolic pulmonary hypertension (CTEPH)

Pulmonary arterial hypertension (PAH)

Exercise pulmonary hypertension/ invasive cardiopulmonary exercise test

Papers, Books, etc. presented or published by your name

1. Yang JZ, Poch DS, Ang L, Mahmud E, Bautista MA, Alotaibi M, Fernandes TM, Kerr KM, Papamatheakis DG, Kim NH. “Tricuspid annular plane systolic excursion to pulmonary artery systolic pressur ratio in chronic thromboembolic pulmonary hypertension improves with balloon pulmonary angioplasty.” Pulmonary Circulation. October 2024;14(4):e12452.

2. Yang JZ, Kim NH, Kligerman S, Fernandes TM, Papamatheakis DG, Poch DS, Alotaibi M, Pretorius VG, Madani MM, Kerr KM. “Outcomes Associated with Catheter-Directed Therapies in Chronic Thromboembolic Pulmonary Hypertension: Cautionary Tales from a Single-center Case Series.” CHEST Pulmonary. September 2023; 1(2):100009. https://doi.org/10.1016/j.chpulm.2023.100009.

3. Yang J, Madani MM, Mahmud E, Kim NH. “Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension.” CHEST. August 2023; 164 (2): 490-502.

4. Yang JZ, Odish MF, Mather H, Pebley N, Wardi G, Kim NH, Papamatheakis DG, Poch DS, Fernandes TM, Sell RE. “Outcomes of Cardiopulmonary Resuscitation in Pulmonary Arterial Hypertension.” Pulmonary Circulation. April 2022. 12(2):e12066.

5. Yang JZ, Fernandes TM, Kim NH, Kerr K, Poch DS, Lombardi S, Melber D, Kelly T, Papamatheakis D. “Pregnancy and pulmonary arterial hypertension: A case series with long term follow up and literature review.” American Journal of Obstetrics & Gynecology: Maternal-Fetal Medicine. July 2021. 3(4):100358.